Lupin Gets USFDA Nod For Generic Risperidone Extended-Release Injectable Suspension

The medicine had estimated annual sales of $190 million in the US, Lupin said, citing IQVIA moving annual toal July 2025 data.

The medicine had estimated annual sales of $190 million in the US, Lupin said, citing IQVIA moving annual toal July 2025 data.

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow